NCT07530367

Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-08-01Est. Completion: 2028-08-01

Enrollment target: 135 participants

Locations

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Contact

Palmoplantar Pustulosis

The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream 20 mg/g co…

Fountain Valley, United StatesEst. completion Dec 14, 2026

Palmoplantar Pustulosis

The purpose of this study is to evaluate the efficacy and safety of bimekizumab compared with placebo in participants wi…

Birmingham, United StatesEst. completion Dec 27, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.